Protein Description

Gene Symbol CXCL8
Entrez ID 3576
Uniprot ID P10145
Descriptionchemokine (C-X-C motif) ligand 8
Chromosomal Locationchr4: 73,740,506-73,743,716
OntologyGO IDGO TermDefinitionEvidence

BP

GO:0001525

angiogenesis

Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.

TAS

BP

GO:0002237

response to molecule of bacterial origin

Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.

IDA

BP

GO:0006928

movement of cell or subcellular component

The directed, self-propelled movement of a cell or subcellular component without the involvement of an external agent such as a transporter or a pore.

TAS

BP

GO:0006935

chemotaxis

The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).

TAS

BP

GO:0006954

inflammatory response

The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.

TAS

BP

GO:0006955

immune response

Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.

IBA

BP

GO:0007050

cell cycle arrest

A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).

IDA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0007186

G-protein coupled receptor signaling pathway

A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576).

TAS

BP

GO:0008285

negative regulation of cell proliferation

Any process that stops, prevents or reduces the rate or extent of cell proliferation.

TAS

BP

GO:0019722

calcium-mediated signaling

Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions.

TAS

BP

GO:0030155

regulation of cell adhesion

Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix.

IDA

BP

GO:0030593

neutrophil chemotaxis

The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.

IGI

BP

GO:0031623

receptor internalization

A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane.

IDA

BP

GO:0034976

response to endoplasmic reticulum stress

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.

IDA

BP

GO:0035556

intracellular signal transduction

The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.

IDA

BP

GO:0036499

PERK-mediated unfolded protein response

A series of molecular signals mediated by the endoplasmic reticulum membrane stress sensor PERK (PKR-like ER kinase). Begins with activation of PERK in response to endoplasmic reticulum (ER) stress and ends with regulation of a downstream cellular process, e.g. transcription. The main substrate of PERK is the translation initiation factor eIF2alpha. Serine-phosphorylation of eIF2alpha by PERK inactivates eIF2alpha and inhibits general protein translation. In addition, eIF2alpha phosphorylation preferentially increases the translation of selective mRNAs such as ATF4 (activating transcription factor 4), which up regulates a subset of UPR genes required to restore folding capacity.

TAS

BP

GO:0042119

neutrophil activation

The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.

TAS

BP

GO:0044344

cellular response to fibroblast growth factor stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.

IEP

BP

GO:0045091

regulation of single stranded viral RNA replication via double stranded DNA intermediate

Any process that modulates the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate.

IDA

BP

GO:0045744

negative regulation of G-protein coupled receptor protein signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of G-protein coupled receptor protein signaling pathway activity.

IDA

BP

GO:0045766

positive regulation of angiogenesis

Any process that activates or increases angiogenesis.

IDA

BP

GO:0048566

embryonic digestive tract development

The process whose specific outcome is the progression of the gut over time, from its formation to the mature structure during embryonic development. The gut is the region of the digestive tract extending from the beginning of the intestines to the anus.

IEP

BP

GO:0050930

induction of positive chemotaxis

Any process that initiates the directed movement of a motile cell or organism towards a higher concentration in a concentration gradient of a specific chemical.

IGI

BP

GO:0070098

chemokine-mediated signaling pathway

A series of molecular signals initiated by the binding of a chemokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IBA

BP

GO:0071222

cellular response to lipopolysaccharide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.

IDA

BP

GO:0071347

cellular response to interleukin-1

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.

IEP

BP

GO:0071356

cellular response to tumor necrosis factor

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.

IEP

BP

GO:0090023

positive regulation of neutrophil chemotaxis

Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.

TAS

BP

GO:2000535

regulation of entry of bacterium into host cell

Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.

IMP

CC

GO:0005576

extracellular region

The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

TAS

CC

GO:0005615

extracellular space

That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

IEA

CC

GO:0005622

intracellular

The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.

IEA

MF

GO:0005153

interleukin-8 receptor binding

Interacting selectively and non-covalently with the interleukin-8 receptor.

IPI

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008009

chemokine activity

The function of a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria.

TAS

Domain IDDescription

IPR001089

CXC chemokine

IPR001811

Chemokine interleukin-8-like domain

IPR018048

CXC chemokine, conserved site

IPR028469

Interleukin-8

IPR033899

CXC Chemokine domain

Pathway IDPathway TermPathway Source

hsa04060

Cytokine-cytokine receptor interaction

KEGG

hsa04062

Chemokine signaling pathway

KEGG

hsa04064

NF-kappa B signaling pathway

KEGG

hsa04072

Phospholipase D signaling pathway

KEGG

hsa04620

Toll-like receptor signaling pathway

KEGG

hsa04621

NOD-like receptor signaling pathway

KEGG

hsa04622

RIG-I-like receptor signaling pathway

KEGG

hsa04657

IL-17 signaling pathway

KEGG

hsa04932

Non-alcoholic fatty liver disease (NAFLD)

KEGG

hsa04933

AGE-RAGE signaling pathway in diabetic complications

KEGG

hsa05120

Epithelial cell signaling in Helicobacter pylori infection

KEGG

hsa05131

Shigellosis

KEGG

hsa05132

Salmonella infection

KEGG

hsa05133

Pertussis

KEGG

hsa05134

Legionellosis

KEGG

hsa05142

Chagas disease (American trypanosomiasis)

KEGG

hsa05144

Malaria

KEGG

hsa05146

Amoebiasis

KEGG

hsa05160

Hepatitis C

KEGG

hsa05161

Hepatitis B

KEGG

hsa05164

Influenza A

KEGG

hsa05200

Pathways in cancer

KEGG

hsa05202

Transcriptional misregulation in cancer

KEGG

hsa05219

Bladder cancer

KEGG

hsa05323

Rheumatoid arthritis

KEGG

WP2431

Spinal Cord Injury

WikiPathways

WP706

Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways

WikiPathways

WP2328

Allograft Rejection

WikiPathways

WP262

EBV LMP1 signaling

WikiPathways

WP3646

Hepatitis C and Hepatocellular Carcinoma

WikiPathways

WP75

Toll-like Receptor Signaling Pathway

WikiPathways

WP2355

Corticotropin-releasing hormone signaling pathway

WikiPathways

WP3287

Overview of nanoparticle effects

WikiPathways

WP3624

Lung fibrosis

WikiPathways

WP2828

Bladder Cancer

WikiPathways

WP3617

Photodynamic therapy-induced NF-kB survival signaling

WikiPathways

WP1449

Regulation of toll-like receptor signaling pathway

WikiPathways

WP3851

TLR4 Signaling and Tolerance

WikiPathways

WP3865

RIG-I-like Receptor Signaling

WikiPathways

WP615

Senescence and Autophagy in Cancer

WikiPathways

WP286

IL-3 Signaling Pathway

WikiPathways

WP3888

VEGFA-VEGFR2 Signaling Pathway

WikiPathways

h_granulocytesPathway

Adhesion and Diapedesis of Granulocytes

BioCarta

h_lympathway

Adhesion and Diapedesis of Lymphocytes

BioCarta

h_LairPathway

Cells and Molecules involved in local acute inflammatory response

BioCarta

h_cytokinePathway

Cytokine Network

BioCarta

h_inflamPathway

Cytokines and Inflammatory Response

BioCarta

h_freePathway

Free Radical Induced Apoptosis

BioCarta

h_il17Pathway

IL 17 Signaling Pathway

BioCarta

h_nthiPathway

NFkB activation by Nontypeable Hemophilus influenzae

BioCarta

h_pepiPathway

Proepithelin Conversion to Epithelin and Wound Repair Control

BioCarta

h_stemPathway

Regulation of hematopoiesis by cytokines

BioCarta

UMLS CUIUMLS Term

C0001418

Adenocarcinoma

C0002965

Angina, Unstable

C0003872

Arthritis, Psoriatic

C0003873

Rheumatoid Arthritis

C0004763

Barrett Esophagus

C0004943

Behcet Syndrome

C0005695

Bladder Neoplasm

C0006625

Cachexia

C0007131

Non-Small Cell Lung Carcinoma

C0007137

Squamous Cell Carcinoma

C0007621

Neoplastic Cell Transformation

C0008370

Cholestasis

C0009324

Ulcerative Colitis

C0009404

Colorectal Neoplasms

C0013080

Down Syndrome

C0013604

Edema

C0014170

Endometrial Neoplasms

C0014869

Peptic Esophagitis

C0015404

Eye Infections, Bacterial

C0015695

Fatty Liver

C0015967

Fever

C0017168

Gastroesophageal Reflux Disease

C0017636

Glioblastoma

C0017658

Glomerulonephritis

C0019202

Hepatolenticular Degeneration

C0020429

Hyperalgesia

C0020542

Pulmonary Hypertension

C0021368

Inflammation

C0022568

Keratitis

C0023283

Leishmaniasis, Cutaneous

C0023290

Leishmaniasis, Visceral

C0024117

Chronic Obstructive Airway Disease

C0030200

Pain, Intractable

C0030297

Pancreatic Neoplasm

C0030805

Bullous Pemphigoid

C0032768

Postherpetic Neuralgia

C0033578

Prostatic Neoplasms

C0034069

Pulmonary Fibrosis

C0035126

Reperfusion Injury

C0038160

Staphylococcal Infections

C0038356

Stomach Neoplasms

C0040136

Thyroid Neoplasm

C0155862

Streptococcal Pneumonia

C0162848

Lichenoid Eruptions

C0919267

Ovarian Neoplasm

C1458155

Mammary Neoplasms

C2239176

Liver Carcinoma

No tissues found.

No databases found.

Pubmed IDAuthorYearTitle

22344199

Chazenbalk et al.

2012

Abnormal Expression of Genes Involved in Inflammation, Lipid Metabolism, and Wnt Signaling in the Adipose Tissue of Polycystic Ovary Syndrome

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

22951915

Haozi et al.

2012

Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome

23824412

Piltonen et al.

2013

Mesenchymal Stem/Progenitors and Other Endometrial Cell Types From Women With Polycystic Ovary Syndrome (PCOS) Display Inflammatory and Oncogenic Potential

Gene SymbolEntrez IDUniprot IDScore

IRF5

3663

Q13568

0.0

NFKB1

4790

P19838

0.0

GNAI2

2771

P04899

0.52

SGTA

6449

O43765

0.63

BAG6

7917

P46379

0.63

ARFGAP3

26286

Q9NP61

0.63

POMGNT1

55624

Q8WZA1

0.63

PF4

5196

P02776

0.65

EP300

2033

Q09472

0.68

IL5

3567

P05113

0.72

ACKR1

2532

Q16570

0.78

CXCR1

3577

P25024

0.88

CXCL8

3576

P10145

0.89

CXCR2

3579

P25025

0.9

CCR1

1230

P32246

0.0

CCR3

1232

P51677

0.0

CCR4

1233

P51679

0.0

CCR7

1236

P32248

0.0

CCR8

1237

P51685

0.0

CX3CR1

1524

P49238

0.0

FOS

2353

P01100

0.0

CCR10

2826

P46092

0.0

CXCL1

2919

P09341

0.0

CXCL3

2921

P19876

0.0

CCL17

6361

Q92583

0.0

CCL19

6363

Q99731

0.0

CCL21

6366

O00585

0.0

CCL22

6367

O00626

0.0

CCL24

6369

O00175

0.0

CX3CL1

6376

P78423

0.0

CXCR4

7852

P61073

0.0

CXCR6

10663

O00574

0.0

CCR9

10803

P51686

0.0

CCR2

729230

P41597

0.0

CTSL

1514

P07711

0.52

DDIT3

1649

P35638

0.52

IL12A

3592

P29459

0.52

MMP9

4318

P14780

0.52

WASF1

8936

Q92558

0.52

CCL4

388372

P13236

0.52

CSNK2A1

1457

P68400

0.65

RELA

5970

Q04206

0.75

CCL5

6352

P13501

0.75

SDC1

6382

P18827

0.75